miR-596 as a novel prognostic biomarker and tumor suppressor in breast cancer through targeting EIF5AL1

In breast cancer, miR-596 suppresses malignancy and predicts prognosis by targeting EIF5AL1. Thus, therapeutic modulation of this axis offers novel avenues for treatment and risk assessment.

Authors

Institutions

Publication Details

Journal
Hereditas
Published
2026-01-22
DOI
https://doi.org/10.1186/s41065-026-00641-6
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

miR-596 as a novel prognostic biomarker and tumor suppressor in breast cancer through targeting EIF5AL1

Yan Bian, Dengyuan Zhong, Rui Huang, Baoyong Lv et al.
Hereditas
MicroRNA in disease regulation
article

miR-596 as a novel prognostic biomarker and tumor suppressor in breast cancer through targeting EIF5AL1

Yan Bian, Dengyuan Zhong, Rui Huang, Baoyong Lv, Yan Jiang
article en

Abstract

In breast cancer, miR-596 suppresses malignancy and predicts prognosis by targeting EIF5AL1. Thus, therapeutic modulation of this axis offers novel avenues for treatment and risk assessment.

HereditasVol. 163(1)
Mudanjiang Medical University (CN), General Hospital of Guangzhou Military Command (CN), Guangzhou Development Zone Hospital (CN), Xi’an International University (CN), Shougang (China) (CN)
Good health and well-being
Openalex Percentile: Top 81%
MicroRNA in disease regulation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.